BeiGene (NASDAQ:ONC) (OTCPK:BEIGF) announced that an advisory committee of the European Medicines Agency (EMA), endorsed its ...

In looking across the past four years of regulatory decisions, we noticed that some of the analyses involving the European Medicines Agency (EMA)'s cycle time used an inappropriate endpoint ...

The European Medicines Agency (EMA) published a workplan on its ambition to leverage high volumes of data and artificial intelligence (AI). On 7 ...

Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

GSK (GSK) stock in focus as its antibody drug conjugate Blenrep gains EMA recommendation for relapsed multiple myeloma with ...

The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...

EMA grants conditional marketing authorization to Autolus’ Aucatzyl to treat adults with acute lymphoblastic leukaemia: Amsterdam, The Netherlands Monday, May 26, 2025, 16:00 Hr ...

QRX003 is currently being evaluated in multiple late-stage clinical trials and is designed to be a topical, non-systemic ...